See how our investment professionals go out into the field to get the full story for you.
Investing in breakthrough therapies

Ziad Bakri puts capital behind ideas with the most potential.

See Story
Strategic investing has guided us since 1937.

Learn how our time-tested approach guides our investment decisions and helps us anticipate and plan for the future.

Put our strategic investing approach to work for you.
Choose from a range of low-cost funds

No matter your goals, you’ll find mutual funds covering nearly every asset class. Or choose from age-based solutions designed with retirement savings and future withdrawals in mind.

Our funds have consistently delivered competitive performance for our clients—all at low cost.


Over 70 of our funds have earned a 4- or 5-star Overall Morningstar Rating™ as of 8/31/192

See what a 1% better return can mean to you.

What seems like a relatively small amount of outperformance can go a long way in your portfolio. Just 1% of additional return over time can have a substantial impact on overall returns. Use the interactive chart to see the impact of earning 1% above the return on the S&P 500 Index benchmark.

additional potential return compared with benchmark
more than S&P 500 Index
Initial Investment
Time Horizon

Results are based on historical year end S&P 500 index returns, ending in 12/31/2018. Time Horizon based on years invested ending on 12/31/2018. The results shown above are hypothetical and for illustrative purposes only and do not represent the performance of any T. Rowe Price mutual fund. The results do not reflect the impact of taxes and investment fees that, if included, would have reduced the results shown. It is not possible to invest directly in an index.

Let us help you get started.

Speak to an investment specialist about solutions that might be right for you. Or explore a selection of funds that put our approach to work.

All mutual funds are subject to market risk, including possible loss of principal.

1169 of our 368 mutual funds had a 10-year track record as of 6/30/19. (Includes all share classes and excludes funds used in insurance products.) 133 of these 169 funds (79%) beat their Lipper average for the 10-year period. 279 of 368 (76%), 231 of 314 (74%), and 178 of 222 (80%) of T. Rowe Price funds outperformed their Lipper average for the 1-, 3-, and 5-year periods ended 6/30/19, respectively. Calculations are based on cumulative total return. Not all funds outperformed for all periods. (Source for data: Lipper Inc.)

2Morningstar gives its best ratings of 5 or 4 stars to the top 32.5% of all funds (of the 32.5%, 10% get 5 stars and 22.5% get 4 stars) based on their risk-adjusted returns. The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund’s 3-, 5-, and 10-year (if applicable) Morningstar Rating™ metrics. As of 8/31/19, 73 of 132 of our Investor Class funds received an overall rating of 5 or 4 stars.

The Morningstar Rating™ for funds, or "star rating," is calculated for funds with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star.

Source for Morningstar data: ©2019 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.